Here you can find about Biotechnology & Biomaterials, their increasing role in the diagnosis, characterization, therapy of various marked diseases and in other crucial fields of biotechnology. Biomaterial does not just include man-made materials which are constructed of metals or ceramics. A biomaterial may also be an autograft, allograft or xenograft used as a transplant material. The union of these technologies promises solutions to recalcitrant problems.
Open Access
Journal of Biotechnology & Biomaterials is an open access scientific journal which is peer-reviewed. It publishes the most exciting researches with respect to the subjects of Biomaterial development and their diagnostic applications. This is freely available online journal which will be soon available as a print.
Objectives
Journal of Biotechnology & Biomaterials aims to provide rapid turn-around era for the reviewers and researchers for publishing their high quality research papers. This journal also helps the people who are into the biological and clinical business to introduce new drugs/biomaterials for the marked disease and wave path for the personal and global development.
Editorial Manager
Journal of Biotechnology & Biomaterials is using online manuscript submission, review and tracking systems of Editorial Manager® for quality and quick review processing. Review processing is performed by the editorial board members of Journal of Biotechnology & Biomaterials or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript.
International Prospectives
Journal of Biotechnology & Biomaterials not only helps researchers, clinicians and scientists, but also renders a link between clinicians, pharmacologists and also the bio-business people who study health effects in populations. Symbiosis of biotechnology and biomaterials are widely used in the applications in tissue engineering of bone and cartilage.
Applying for a waiver or discount please e-mail(info@omicsonline.org) to the managing editor with proposed title and abstract.
